Literature DB >> 8606802

Presynaptic inhibition of excitatory synaptic transmission by muscarinic and metabotropic glutamate receptor activation in the hippocampus: are Ca2+ channels involved?

M Scanziani1, B H Gahwiler, S M Thompson.   

Abstract

Activation of either muscarinic cholinergic or metabotropic glutamatergic presynaptic receptors inhibits evoked excitatory synaptic responses in the hippocampus. We have investigated two possible mechanisms underlying these actions using whole-cell recording from CA3 pyramidal cells in hippocampal slice cultures. Application of either methacholine (MCh, 10 microM) or trans-aminocyclopentane-1,3-dicarboxylic acid (t-ACPD, 10 microM) was found to reduce the frequency of miniature excitatory postsynaptic currents (mEPSCs) by roughly 50%, without changing their mean amplitude. The voltage-dependent Ca2+ channel blocker Cd2+ (100 microM), in contrast, had no effect on the mEPSC frequency. When the extracellular [K+] was increased from 2.7 to 16 mM, the mEPSC frequency increased from 1.7 to 4.9 Hz. This increase could be completely reversed by applying Cd2+, indicating that it was triggered by voltage-dependent Ca2+ influx. MCh and t-ACPD each decreased the mEPSC frequency by roughly 50% under these conditions. Because the agonists were equally effective in inhibiting spontaneous release whether voltage-dependent channels were activated or not, we conclude that presynaptic cholinergic and glutamatergic inhibition is not mediated by inhibition of presynaptic Ca2+ channels, but rather by a direct interference in the neurotransmitter release process at some point subsequent to Ca2+ influx.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8606802     DOI: 10.1016/0028-3908(95)00119-q

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  53 in total

1.  Dual mechanism for presynaptic modulation by axonal metabotropic glutamate receptor at the mouse mossy fibre-CA3 synapse.

Authors:  H Kamiya; S Ozawa
Journal:  J Physiol       Date:  1999-07-15       Impact factor: 5.182

2.  Correlation of miniature synaptic activity and evoked release probability in cultures of cortical neurons.

Authors:  O Prange; T H Murphy
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

3.  Activation of group II metabotropic glutamate receptors inhibits synaptic excitation of the substantia Nigra pars reticulata.

Authors:  S R Bradley; M J Marino; M Wittmann; S T Rouse; H Awad; A I Levey; P J Conn
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

Review 4.  Metabotropic glutamate receptors in vertebrate retina.

Authors:  Urs Gerber
Journal:  Doc Ophthalmol       Date:  2003-01       Impact factor: 2.379

5.  Dopamine depresses excitatory and inhibitory synaptic transmission by distinct mechanisms in the nucleus accumbens.

Authors:  S M Nicola; R C Malenka
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

6.  PICK1 is required for the control of synaptic transmission by the metabotropic glutamate receptor 7.

Authors:  J Perroy; O El Far; F Bertaso; J P Pin; H Betz; J Bockaert; L Fagni
Journal:  EMBO J       Date:  2002-06-17       Impact factor: 11.598

7.  Muscarinic inhibition of recurrent glutamatergic excitation in frog tectum column prevents NMDA receptor activation on efferent neuron.

Authors:  Armantas Baginskas; Antanas Kuras
Journal:  Exp Brain Res       Date:  2010-11-17       Impact factor: 1.972

Review 8.  GPCR mediated regulation of synaptic transmission.

Authors:  Katherine M Betke; Christopher A Wells; Heidi E Hamm
Journal:  Prog Neurobiol       Date:  2012-01-28       Impact factor: 11.685

Review 9.  Gβγ SNARE Interactions and Their Behavioral Effects.

Authors:  Simon Alford; Heidi Hamm; Shelagh Rodriguez; Zack Zurawski
Journal:  Neurochem Res       Date:  2018-05-11       Impact factor: 3.996

10.  Neuronal mechanisms of the anoxia-induced network oscillations in the rat hippocampus in vitro.

Authors:  V Dzhala; I Khalilov; Y Ben-Ari; R Khazipov
Journal:  J Physiol       Date:  2001-10-15       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.